NGO · Spain
not in the EU Transparency RegisterThis organization files on consultations without a register number, so its record here is built from its filings alone. Register facts (staff, costs, accreditations) are not available for it.
Counts here are a floor, never a total: they cover the 665 consultation files tracked so far (57,800 submissions, mostly 2021–26), so an organization's real filing history is larger, not smaller.
Track Asociación in PolicySpeak: request access →
Work at Asociación Hipofam? so we know who speaks for it.
Asociación Hipofam filed 2 positions between 26 Dec 2020 and 12 Nov 2025, across 2 of the 665 legislative files tracked here.
Since Hipofam, we welcome the proposed changes and the willingness to improve access to and development of medicines for paediatric patients, and thus how improvements to the system of incentives for medicines for rare diseases. Although inclusion and reimbursement fall within the competence of the States, measures to improve fairness in access across the EU should be considered.
Filed in Spanish · English published by the European Commission
1Health as an EU priority The best way to safeguard public health is through a dedicated health programme at European level, with protected funding and building on the achievements of the EU4Health programme. 2. Integrating health and rare diseases into the ECF The European Competitiveness Fund (ECF) should explicitly include and adequately support public health and rare disease actions.
Filed in Spanish · English published by the European Commission
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Put Asociación Hipofam next to another organization. Same files, same register facts, side by side. Compare →
Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers, not evidence of coordination, and we do not suggest any.
Everything on this page comes from Asociación Hipofam’s own submissions to the European Commission. We have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.